Short communication · 4 Aug 2026
Conference abstractPublished 15 Apr 2013
The effect of trimetazidine in the ischemia-reperfusion injury in myocardial revascularization surgery
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: The objective of this study was to determine whether trimetazidine could reduce myocardial reperfusion injury damage in coronary artery bypass graft surgery (CABG) using evolutive serial troponin T and CPK-MB blood levels and to verify possible follow-up changes in left ventricular (LV) echocardiographyc function, and also the frequency of the ventricular fibrillation at the end of bypass. Methods: We conduced a double-blind, placebo-controlled study on 60 randomized pacients undergoing CABG.The TMZ group was composed of 30 patients and the placebo group of 30 patients.They were stratified by echocardioghy (2D echo) in order to include only patients with normal and/or mild LV dysfunction. After the initial assessment they were submitted to serial troponin T and CPK-MB blood levels, in four distinct moments: pre-operative without medication, five minutes after aortic unclamping taken from the right atrium, with at least ten days of medication or placebo, and 12, 24 and 48 hours after surgery from the central venous catheter. Order of 2D echo measurements were performed: without medication, on the day of surgery with the use of ten days of medication/placebo and after leaving the ICU with at least fifteen days of medication/placebo. The ventricular fibrillation was verified through cardioscopic and direct transthoracic observation after bypass. Results: Troponin T reached in samples analyzed by time in the group treated compared with the control group the following values:? 5 min (p = 0001); 12h (p = 0001); 24h (p = 0001); 48h(p=0.0001). The CPK-MB isoenzyme reached the following values: 5 min (p = 0001); 12h (p = 0001); 24h (p = 0001); 48h (p = 0001). Echocardiographic variables studied showed no follow-up changes in the groups. The frequency of ventricular fibrillation was low in both groups. Conclusions and clinical implications: These results obtained by measurement of cardiac TnT and CPK-MB suggested that pretreatment with trimetazidine reduces ischemic-reperfusion damage during coronary bypass surgery but did not affect LV 2D echo variables and showed no differences in the incidence of ventricular fibrillation without side effects in the groups studied
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical and Experimental Cardiology.
Conference abstract · 15 Jun 2026
Speckle Tracking Echocardiography for Early Identification of Chemotherapy-Induced Cardiotoxicity
Conference abstract · 15 Jun 2026
Coronary CT Angiography as a First-Line Diagnostic Tool for Stable Chest Pain: Clinical Outcomes from a Multicenter Study
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Gerez Fernandes Martins”
- BylineArticles whose byline prints “Aristarco Gonçalves De Siqueira Filho”
- BylineArticles whose byline prints “Joao Bosco De Fiqueiredo Santos”
- BylineArticles whose byline prints “Claudio Roberto Cavalcanti Assuncao”
- BylineArticles whose byline prints “Francisca Bottino”
- BylineArticles whose byline prints “Kattia Gerundio De Carvalho”
- BylineArticles whose byline prints “Alberto Valencia”
